Texas Halo Fund is the famous VC, which was founded in 2012. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Houston.
The current fund was established by Andrew Clark, David Steakley, Kevin King, Robert Tucci.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Texas Halo Fund, startups are often financed by Mercury Fund, Tech Coast Angels, TriStar Health Partners. The meaningful sponsors for the fund in investment in the same round are Tech Coast Angels, Pipeline Angels, K5 Ventures. In the next rounds fund is usually obtained by Houston Angel Network, MedTech Innovator, Techstars Los Angeles Accelerator.
Among the various public portfolio startups of the fund, we may underline Onit, DNAtriX, Quad Technologies For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Health Care, Biotechnology. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The high activity for fund was in 2016. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. Deals in the range of 1 - 5 millions dollars are the general things for fund. The typical startup value when the investment from Texas Halo Fund is 1-5 millions dollars. Opposing the other organizations, this Texas Halo Fund works on 22 percentage points less the average amount of lead investments.
Related Funds
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vartega Inc. | $5M | 16 Aug 2022 | Golden, Colorado, United States | ||
Rellevate | 25 Feb 2022 | Stamford, Connecticut, United States | |||
Global Neighbor | $1M | 09 Dec 2021 | Dayton, Ohio, United States | ||
Vartega Inc. | 18 Nov 2021 | Golden, Colorado, United States | |||
Resonant Therapeutics | 26 Oct 2021 | Santa Barbara, California, United States | |||
ReturnSafe | 21 Sep 2021 | Austin, Texas, United States | |||
kegg | $3M | 31 Aug 2021 | San Francisco, California, United States | ||
Allotrope Medical | $4M | 01 Jun 2021 | Houston, Texas, United States | ||
Galen Data | 29 May 2021 | Houston, Texas, United States |
– Allotrope Medical, a Houston, TX-based medical device company, closed a $4m Series A funding.
– The round was led by Rockies Venture Club (RVC), with participation from Aggie Angel Network, Bellingham Angels, Berkeley Angel Network, Kentucky Select Fund, MEDA Angels, Prosalus Capital, Seedfolio, Tech Coast Angels (Orange County and San Diego), and Texas Halo Fund.
– The new investment will be used to continue to accelerate the company’s commercialization plans.
– Sonnest, Inc. raised more than $4M in an oversubscribed Series A financing.
– The round was led by the SWAN Impact Network, Robin Hood Ventures and the Texas Halo Fund and included a number of doctors, and prominent angel investors.
– The funds will be used to advance Electrast™ into the clinic, confirm the safety profile of the drug and generate proof-of-principle ultrasound images in human patients similar to the videos created to date in pigs and dogs.
– The company is also announcing that it has selected a new CEO, Peter Boyd, who is a serial healthcare entrepreneur who sold his last company to Edwards Lifesciences for $100M upfront and up to $150M in milestone payments.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vartega Inc. | $5M | 16 Aug 2022 | Golden, Colorado, United States | ||
Rellevate | 25 Feb 2022 | Stamford, Connecticut, United States | |||
Global Neighbor | $1M | 09 Dec 2021 | Dayton, Ohio, United States | ||
Vartega Inc. | 18 Nov 2021 | Golden, Colorado, United States | |||
Resonant Therapeutics | 26 Oct 2021 | Santa Barbara, California, United States | |||
ReturnSafe | 21 Sep 2021 | Austin, Texas, United States | |||
kegg | $3M | 31 Aug 2021 | San Francisco, California, United States | ||
Allotrope Medical | $4M | 01 Jun 2021 | Houston, Texas, United States | ||
Galen Data | 29 May 2021 | Houston, Texas, United States |
